Previous Page  69 / 74 Next Page
Information
Show Menu
Previous Page 69 / 74 Next Page
Page Background

69

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

105

Price, D.D. and R. Staud, Neurobiology of fibromyalgia syndrome. Journal of Rheumatolo-

gy – Supplement, 2005. 75: p. 22-8.

106

Raffa RB JPergolizzi JV Jr The evolving understanding of the analgesic mechanism of

action of flupirtine Clin Pharm Ther. 2012 Feb;37(1):4-6

107

Ramel, J., et al., Exercise for Fibromyalgia Pain: A Meta-Analysis of Randomized Cont-

rolled Trials. Current Rheumatology Reviews, 2009.5(4): p. 188-193.

108

Rao, S.G. and D.J. Clauw, The management of fibromyalgia. Drugs of Today, 2004. 40(6):

p. 539-54.

109

Rehm, S.E., et al., A cross-sectional survey of 3035 patients with fibromyalgia: subgroups

of patients with typical comorbidities and sensory symptom profiles. Rheumatology,

2010. 49(6): p. 1146-52

110

Richards BL, Muscle relaxants for pain management in rheumatoid arthritis Cochrane

Database Syst Rev. 2012 Jan 18;1

111

Rivera J Drug prescription strategies in the treatment of patients with fibromyalgia. Reu-

matol Clin. 2012 Jul-Aug;8(4):184-8.

112

Rodriguez-Andreu, J., et al., Cognitive impairment in patients with fibromyalgia syndrome

as assessed by the mini-mental state examination.BMC Musculoskeletal Disorders, 2009.

10: p. 162

113

Roskell NS1, Beard SM, Zhao Y, Le TK, A meta-analysis of pain response in the treatment

of fibromyalgia.

114

Roskell NS1, Beard SM, Zhao Y, Le TK, A meta-analysis of pain response in the treatment

of fibromyalgia. Pain Pract. 2011 Nov-Dec;11(6):516-27

115

Rossy, L.A., et al., A meta-analysis of fibromyalgia treatment interventions. Annals of

Behavioral Medicine, 1999. 21(2): p. 180-91

116

Roy-Byrne, P., et al., Post-traumatic stress disorder among patients with chronic pain and

chronic fatigue. Psychological Medicine, 2004.34(2): p. 363-368.

117

Ruiz-Perez, I., et al., Risk factors for fibromyalgia: the role of violence against women. Clin

Rheumatol, 2009. 28(7): p. 777-86.

118

Schneider, M.J., Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome:

a need for clarity in terminology and differential diagnosis. Journal of Manipulative &

Physiological Therapeutics, 1995. 18(6): p. 398-406

119

Siler, A.C., et al., Systematic review of the comparative effectiveness of antiepileptic drugs

for fibromyalgia. Journal of Pain, 2011. 12(4): p. 407-15.

120

Skrabek, R.Q., et al., Nabilone for the treatment of pain in fibromyalgia. Journal of Pain,

2008. 9(2): p. 164-73.

121

Smith, S.B., et al., Large candidate gene association study reveals genetic risk factors and

therapeutic targets for fibromyalgia. Arthritis Rheum, 2011

122

Soni, P., et al., The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID

celecoxib: pooled analysis of 41 randomized controlled trials. Current Medical Research

& Opinion, 2009. 25(8): p. 1841-51.